F.D.A. Modernization Act

The FDA Modernization Act, enacted in 1997, aimed to improve the efficiency of the U.S. Food and Drug Administration. It streamlined the drug approval process, making it faster for new medications to reach the market while ensuring safety. The Act promoted the use of "fast track" procedures for serious conditions, encouraged innovation in manufacturing, and emphasized the use of modern technology in drug development. Additionally, it allowed for the compounding of medicines by pharmacists to better meet patient needs, enhancing flexibility in pharmaceutical care. Overall, it sought to balance timely access to treatments with public health protections.